World Health Organisation’s (WHO’s) Chief Scientist -- Dr Soumya Swaminathan has said that it is very important for India to have a strong regulatory system to remain a leader in the generic medicine and vaccines space. She mentioned ‘I think it's going to be very important for the reputation and ultimately for India to remain as a leader in the generic medicine and vaccines space to prove beyond doubt that we have a very strong regulatory system.’
India has sought more information from WHO about the initial illness, symptoms and treatment provided to the Gambian children who died allegedly after consuming contaminated cough syrups manufactured by a Sonepat-based company. Soumya said pharmaceutical contamination is a serious issue and should be taken seriously.
She stated ‘WHO actually provided the report based on the investigation that was done to prove that it was because of the Diethylene glycol (DEG) contamination, it's a serious issue, I think it has to be taken very seriously.’ She added 'We have the central and the state regulators. We need to look at the rules of operation and see how we harmonise these.’
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: